These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

421 related items for PubMed ID: 18044777

  • 1. Analysis of bifurcation lesions treated with novel drug-eluting dedicated bifurcation stent system: intravascular ultrasound results of the AXXESS PLUS trial.
    Miyazawa A, Ako J, Hassan A, Hasegawa T, Abizaid A, Verheye S, McClean D, Neumann FJ, Grube E, Honda Y, Fitzgerald PJ.
    Catheter Cardiovasc Interv; 2007 Dec 01; 70(7):952-7. PubMed ID: 18044777
    [Abstract] [Full Text] [Related]

  • 2. Analysis of left main coronary artery bifurcation lesions treated with biolimus-eluting DEVAX AXXESS plus nitinol self-expanding stent: intravascular ultrasound results of the AXXENT trial.
    Hasegawa T, Ako J, Koo BK, Miyazawa A, Sakurai R, Chang H, Dens J, Verheye S, Grube E, Honda Y, Fitzgerald PJ.
    Catheter Cardiovasc Interv; 2009 Jan 01; 73(1):34-41. PubMed ID: 19089934
    [Abstract] [Full Text] [Related]

  • 3. Baseline and 9 months IVUS analysis of the bifurcation-dedicated biolimus A9-eluting Axxess stent system: the DIVERGE IVUS substudy.
    Buysschaert I, Sanidas E, Hasegawa T, Koo BK, Honda Y, Fitzgerald PJ, Verheye S.
    Catheter Cardiovasc Interv; 2014 Dec 01; 84(7):1062-70. PubMed ID: 24478226
    [Abstract] [Full Text] [Related]

  • 4. Intravascular ultrasound results from the ENDEAVOR IV trial: randomized comparison between zotarolimus- and paclitaxel-eluting stents in patients with coronary artery disease.
    Waseda K, Miyazawa A, Ako J, Hasegawa T, Tsujino I, Sakurai R, Yock PG, Honda Y, Kandzari DE, Leon MB, Fitzgerald PJ, ENDEAVOR IV Trial Investigators.
    JACC Cardiovasc Interv; 2009 Aug 01; 2(8):779-84. PubMed ID: 19695548
    [Abstract] [Full Text] [Related]

  • 5. 9-month clinical, angiographic, and intravascular ultrasound results of a prospective evaluation of the Axxess self-expanding biolimus A9-eluting stent in coronary bifurcation lesions: the DIVERGE (Drug-Eluting Stent Intervention for Treating Side Branches Effectively) study.
    Verheye S, Agostoni P, Dubois CL, Dens J, Ormiston J, Worthley S, Trauthen B, Hasegawa T, Koo BK, Fitzgerald PJ, Mehran R, Lansky AJ.
    J Am Coll Cardiol; 2009 Mar 24; 53(12):1031-9. PubMed ID: 19298915
    [Abstract] [Full Text] [Related]

  • 6. Intravascular ultrasound analysis of small vessel lesions treated with the Sparrow coronary stent system: results of the CARE II trial.
    Kume T, Waseda K, Koo BK, Yock PG, Botelho R, Verheye S, Whitbourn R, Meredith I, Worthley S, Hai KT, Honda Y, Abizaid A, Fitzgerald PJ.
    Catheter Cardiovasc Interv; 2014 Jan 01; 83(1):19-24. PubMed ID: 23413202
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of reduced-dose sirolimus-eluting stents in the human coronary artery: serial IVUS analysis of neointimal hyperplasia and luminal dimension.
    Nakamura M, Abizaid A, Hirohata A, Honda Y, Sousa JE, Fitzgerald PJ.
    Catheter Cardiovasc Interv; 2007 Dec 01; 70(7):946-51. PubMed ID: 17621671
    [Abstract] [Full Text] [Related]

  • 8. Comparative Case-Control analysis of a dedicated self-expanding Biolimus A9-eluting Bifurcation stent versus provisional or mandatory side branch intervention strategies in the treatment of coronary bifurcation lesions.
    Ohlow MA, Farah A, Richter S, El-Garhy M, von Korn H, Lauer B.
    Catheter Cardiovasc Interv; 2017 Jul 01; 90(1):39-47. PubMed ID: 27651317
    [Abstract] [Full Text] [Related]

  • 9. Impact of side branch stenting on five-year long-term clinical outcome with the bifurcation-dedicated Axxess Biolimus A9-eluting stent system.
    Verheye S, Buysschaert I, Grube E.
    EuroIntervention; 2015 Dec 01; 11(8):860-7. PubMed ID: 26696454
    [Abstract] [Full Text] [Related]

  • 10. DANUBIO - a new drug-eluting balloon for the treatment of side branches in bifurcation lesions: six-month angiographic follow-up results of the DEBSIDE trial.
    Berland J, Lefèvre T, Brenot P, Fajadet J, Motreff P, Guerin P, Dupouy P, Schandrin C, DEBSIDE trial investigators.
    EuroIntervention; 2015 Dec 01; 11(8):868-76. PubMed ID: 26696455
    [Abstract] [Full Text] [Related]

  • 11. Long-term clinical and angiographic outcomes after implantation of sirolimus-eluting stents with a "modified mini-crush" technique in coronary bifurcation lesions.
    Yang HM, Tahk SJ, Woo SI, Lim HS, Choi BJ, Choi SY, Yoon MH, Park JS, Zheng M, Hwang GS, Kang SJ, Shin JH.
    Catheter Cardiovasc Interv; 2009 Jul 01; 74(1):76-84. PubMed ID: 19360861
    [Abstract] [Full Text] [Related]

  • 12. Impact of diabetes mellitus on vessel response in the drug-eluting stent era: pooled volumetric intravascular ultrasound analyses.
    Sakata K, Waseda K, Kume T, Otake H, Nakatani D, Yock PG, Fitzgerald PJ, Honda Y.
    Circ Cardiovasc Interv; 2012 Dec 01; 5(6):763-71. PubMed ID: 23149332
    [Abstract] [Full Text] [Related]

  • 13. Comparison of vascular response to zotarolimus-eluting stent vs paclitaxel-eluting stent implantation: pooled IVUS results from the ZoMaxx I and II trials.
    Waseda K, Hasegawa T, Ako J, Honda Y, Grube E, Whitbourn R, Ormiston J, O'Shaughnessy CD, Henry TD, Overlie P, Schwartz LB, Sudhir K, Chevalier B, Gray WA, Yeung AC, Fitzgerald PJ, ZoMaxx I and II Trial Investigators.
    Circ J; 2010 Nov 01; 74(11):2334-9. PubMed ID: 20890052
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Results of the self-expandable BA9 stent for treatment of large angle coronary bifurcation.
    Lucisano L, Calcagno S, Pennacchi M, Stio RE, Mancone M, Sardella G.
    Minerva Cardioangiol; 2014 Feb 01; 62(1):19-27. PubMed ID: 24500214
    [Abstract] [Full Text] [Related]

  • 16. 12-month intravascular ultrasound observations from BiOSS® first-in-man studies.
    Gil RJ, Bil J, Costa RA, Gil KE, Vassiliev D.
    Int J Cardiovasc Imaging; 2016 Sep 01; 32(9):1339-1347. PubMed ID: 27314841
    [Abstract] [Full Text] [Related]

  • 17. Polymer-free Biolimus A9-coated stents in the treatment of de novo coronary lesions with short DAPT: 9-month angiographic and clinical follow-up of the prospective, multicenter BioFreedom USA clinical trial.
    Waksman R, Piegari GN, Kabour A, Cannon L, Wang J, Adams G, Solankhi N, Smeglin A, Kereiakes DJ, Leiboff R, Spad MA, Torguson R, Chandra N, Bastian R, DeGroot J, Kayo MW, Stoll HP, Garcia-Garcia HM.
    Cardiovasc Revasc Med; 2017 Sep 01; 18(7):475-481. PubMed ID: 28923692
    [Abstract] [Full Text] [Related]

  • 18. Segmental comparison between a dedicated bifurcation stent and balloon angioplasty using intravascular ultrasound and three-dimensional quantitative coronary angiography: A subgroup analysis of the Tryton IDE randomized trial.
    Grundeken MJ, Garcia-Garcia HM, Kumsars I, Lesiak M, Kayaert P, Dens J, Stella PR, de Winter RJ, Laak LL, Généreux P, Kaplan AV, Leon MB, Wykrzykowska JJ, Onuma Y, Serruys PW.
    Catheter Cardiovasc Interv; 2017 Feb 01; 89(2):E53-E63. PubMed ID: 27083384
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
    Ormiston J, Webster M, Stewart J, Vrolix M, Whitbourn R, Donohoe D, Knape C, Lansky A, Attizzani GF, Fitzgerald P, Kandzari DE, Wijns W.
    JACC Cardiovasc Interv; 2013 Oct 01; 6(10):1026-34. PubMed ID: 24055443
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.